Malik Rajesh

CIK 00017068532 companiesRESEARCH TRIANGLE PARK, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001706853

Recent Transactions

19 trades

Disposition from Tender
G1 Therapeutics, Inc.
Common Stock
2024-09-18−87,450→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−35,700→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−57,333→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−36,924→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Common Stock
2024-09-18−89,762→ 87,450 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-09-18+17,900→ 177,212 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−74,500→ 0 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-07-05$2.51/sh−2,475→ 159,312 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-05-13$4.79/sh−8,151→ 161,787 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-02-12$4.62/sh−28,600→ 169,938 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2024-02-12−28,600→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2024-02-12$0.30/sh+28,600→ 198,538 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-04$2.94/sh−721→ 169,938 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−758→ 172,920 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-01-03+37,300→ 173,678 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2024-01-03+74,500→ 74,500 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−2,261→ 170,659 total
Purchase
POINT Biopharma Global Inc.
Common Stock
2022-11-28$6.66/sh+3,700→ 3,700 total
Award
POINT Biopharma Global Inc.
Stock Option (Right to Buy)
2022-06-02+25,614→ 25,614 total

Companies

Recent Filings

Address

700 PARK OFFICES DRIVE, SUITE 200

RESEARCH TRIANGLE PARK, NC, 27709

View on SEC.gov